BioSpace News Archive

Business

Alzheon Appoints Former IVAX President, Neil Flanzraich, JD, as Vice Chairman of Board of Directors

Mr. Flanzraich was an early investor in Alzheon and served in the role of Chief Business Officer of Alzheon as a consultant to the company from February to May 2018.

August 6, 2018
·
4 min read
Business

Surmodics Reports Third Quarter Fiscal 2018 Results

Revenue of $22.2 million, up 24.9%

August 6, 2018
·
15 min read
Business

AOBiome Therapeutics Announces the Expansion of its Board of Directors

New appointments integrate broad expertise in clinical development, medicine, finance and business management.

August 6, 2018
·
5 min read
BioMidwest

NexGen Medical Systems, Inc. Launches XCOIL® Large Vessel (18mm) Thrombectomy System

Limited Market Release expands the utility of the XCOIL® for Deep Vein Thrombosis

August 6, 2018
·
2 min read
Business

Ironwood Pharmaceuticals Provides Second Quarter 2018 Investor Update

Second quarter revenue increased 25% year-over-year to $81 million, driven primarily by LINZESS® (linaclotide) U.S. net sales of $192 million and commercial margin of 60%

August 6, 2018
·
42 min read
Drug Development

Harpoon Therapeutics Treats First Patient with HPN424 in Phase 1 Clinical Trial of Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients

Harpoon Therapeutics, today that the first patient has been treated with HPN424 in a Phase 1 clinical study of metastatic castration-resistant prostate cancer patients.

August 6, 2018
·
4 min read
Business

Immune Biosolutions Enters into a Research Collaboration and License Agreement with Johnson & Johnson Innovation to Identify and Develop Therapeutic Antibodies for Multiple Targets

Immune Biosolutions Inc. announced a research collaboration and license agreement with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson.

August 6, 2018
·
1 min read
LivaNova Concludes PRELUDE Study for Transcatheter Mitral Valve Replacement System

Company now focused on INTERLUDE CE Mark trial, building upon positive patient outcomes

August 6, 2018
·
5 min read
FDA

Alteogen Gets FDA Approval for Orphan Drug Designation with an Antibody-Drug Conjugate for Gastric Cancer

Alteogen Inc. announced that it has successfully got an approval for orphan drug designation from the Food and Drug Administration with one of its assets for gastric cancer.

August 6, 2018
·
2 min read
Business

Marina Biotech Appoints Jay D. Schwartz to serve as Senior Vice President, Commercial Operations

Marina Biotech, Inc. announced that the company has appointed Jay D. Schwartz to serve as Senior Vice President, Commercial Operations.

August 6, 2018
·
4 min read